Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy

Abstract Background Hepatic steatosis has become a major worldwide health problem, so assessment of hepatic steatosis in potential living donors is crucial prior to liver transplantation. Until now liver biopsy (LB) is considered the gold standard for diagnosing steatosis before transplantation, how...

Full description

Bibliographic Details
Main Authors: Hesham Mohamed Atef, Enas Mohamed Korayem, Naglaa Allam Ahmed, Mohamed Mohamed Houseni, Ahmed Mohamed El-Refaie, Manal Ibrahim Gomaa
Format: Article
Language:English
Published: SpringerOpen 2023-12-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Online Access:https://doi.org/10.1186/s43055-023-01165-z
_version_ 1797398108182675456
author Hesham Mohamed Atef
Enas Mohamed Korayem
Naglaa Allam Ahmed
Mohamed Mohamed Houseni
Ahmed Mohamed El-Refaie
Manal Ibrahim Gomaa
author_facet Hesham Mohamed Atef
Enas Mohamed Korayem
Naglaa Allam Ahmed
Mohamed Mohamed Houseni
Ahmed Mohamed El-Refaie
Manal Ibrahim Gomaa
author_sort Hesham Mohamed Atef
collection DOAJ
description Abstract Background Hepatic steatosis has become a major worldwide health problem, so assessment of hepatic steatosis in potential living donors is crucial prior to liver transplantation. Until now liver biopsy (LB) is considered the gold standard for diagnosing steatosis before transplantation, however steatosis assessment using imaging modalities, such as computerized tomography (CT), would be better for the donor, due its non-invasiveness. This study aimed to assess the efficacy of CT as a semiquantitaive tool for liver steatosis assessment in liver donors in comparison to liver biopsy results. Methods This cross-sectional study was carried out on 53 potential liver graft donors. All patients were subjected to non-contrast CT of the abdomen, tru-cut liver biopsy, and histopathological evaluation. The CT liver attenuation (CTL), the hepatic/splenic CT attenuation ratio (CTL/S) and difference between hepatic attenuation value and splenic attenuation values (CTL–S) were determined as well as the correlations of these indices and the findings of Liver biopsy (LB) were compared. Results According to the hepatosteatosis grades in the pathology results, the patients were divided into two groups: group A: 38 patients with grade 0 hepatosteatosis and group B: 15 patients with grade 1 and 2 hepatosteatosis. CTL, CTL–S, CTL/S, ratio of mean right hepatic lobe and splenic attenuation (RT/S) and ratio of mean left hepatic lobe and splenic attenuation (LT/S) were found to be effective in the diagnosis of hepatosteatosis grades at cutoff values ≤ 55.4, ≤ 8.7, ≤ 1.17, ≤ 1.1548 and ≤ 1.2971 with 80%, 80%, 73.3%, 86.7% and 86.7% sensitivity and 71.1%, 56.8%, 73.7% 71.1% and 50.0% specificity respectively. Also, CTL/S was found to be very effective in the diagnosis of grade II hepatosteatosis at cutoff values ≤ 0.9 with 100% sensitivity and 100% specificity. There was significant negative correlations between the CT indexes and degree of hepatosteatosis. Conclusions Compared to biopsy results, CT noninvasive indices strongly predicted the presence of hepatosteatosis, which can help in avoiding the necessity for this invasive technique.
first_indexed 2024-03-09T01:20:55Z
format Article
id doaj.art-e13ca4d8610c46c0981f2c6fde54a184
institution Directory Open Access Journal
issn 2090-4762
language English
last_indexed 2024-03-09T01:20:55Z
publishDate 2023-12-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Radiology and Nuclear Medicine
spelling doaj.art-e13ca4d8610c46c0981f2c6fde54a1842023-12-10T12:11:51ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine2090-47622023-12-015411910.1186/s43055-023-01165-zAssessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsyHesham Mohamed Atef0Enas Mohamed Korayem1Naglaa Allam Ahmed2Mohamed Mohamed Houseni3Ahmed Mohamed El-Refaie4Manal Ibrahim Gomaa5National Liver Institute, Menoufia UniversityNational Liver Institute, Menoufia UniversityNational Liver Institute, Menoufia UniversityNational Liver Institute, Menoufia UniversityNational Liver Institute, Menoufia UniversityNational Liver Institute, Menoufia UniversityAbstract Background Hepatic steatosis has become a major worldwide health problem, so assessment of hepatic steatosis in potential living donors is crucial prior to liver transplantation. Until now liver biopsy (LB) is considered the gold standard for diagnosing steatosis before transplantation, however steatosis assessment using imaging modalities, such as computerized tomography (CT), would be better for the donor, due its non-invasiveness. This study aimed to assess the efficacy of CT as a semiquantitaive tool for liver steatosis assessment in liver donors in comparison to liver biopsy results. Methods This cross-sectional study was carried out on 53 potential liver graft donors. All patients were subjected to non-contrast CT of the abdomen, tru-cut liver biopsy, and histopathological evaluation. The CT liver attenuation (CTL), the hepatic/splenic CT attenuation ratio (CTL/S) and difference between hepatic attenuation value and splenic attenuation values (CTL–S) were determined as well as the correlations of these indices and the findings of Liver biopsy (LB) were compared. Results According to the hepatosteatosis grades in the pathology results, the patients were divided into two groups: group A: 38 patients with grade 0 hepatosteatosis and group B: 15 patients with grade 1 and 2 hepatosteatosis. CTL, CTL–S, CTL/S, ratio of mean right hepatic lobe and splenic attenuation (RT/S) and ratio of mean left hepatic lobe and splenic attenuation (LT/S) were found to be effective in the diagnosis of hepatosteatosis grades at cutoff values ≤ 55.4, ≤ 8.7, ≤ 1.17, ≤ 1.1548 and ≤ 1.2971 with 80%, 80%, 73.3%, 86.7% and 86.7% sensitivity and 71.1%, 56.8%, 73.7% 71.1% and 50.0% specificity respectively. Also, CTL/S was found to be very effective in the diagnosis of grade II hepatosteatosis at cutoff values ≤ 0.9 with 100% sensitivity and 100% specificity. There was significant negative correlations between the CT indexes and degree of hepatosteatosis. Conclusions Compared to biopsy results, CT noninvasive indices strongly predicted the presence of hepatosteatosis, which can help in avoiding the necessity for this invasive technique.https://doi.org/10.1186/s43055-023-01165-zHepatic steatosisLiver transplantationCT IndicesLiver biopsy
spellingShingle Hesham Mohamed Atef
Enas Mohamed Korayem
Naglaa Allam Ahmed
Mohamed Mohamed Houseni
Ahmed Mohamed El-Refaie
Manal Ibrahim Gomaa
Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
The Egyptian Journal of Radiology and Nuclear Medicine
Hepatic steatosis
Liver transplantation
CT Indices
Liver biopsy
title Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
title_full Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
title_fullStr Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
title_full_unstemmed Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
title_short Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
title_sort assessment of hepatic steatosis of potential living donor before liver transplantation using liver spleen ct attenuation ratio compared to liver biopsy
topic Hepatic steatosis
Liver transplantation
CT Indices
Liver biopsy
url https://doi.org/10.1186/s43055-023-01165-z
work_keys_str_mv AT heshammohamedatef assessmentofhepaticsteatosisofpotentiallivingdonorbeforelivertransplantationusingliverspleenctattenuationratiocomparedtoliverbiopsy
AT enasmohamedkorayem assessmentofhepaticsteatosisofpotentiallivingdonorbeforelivertransplantationusingliverspleenctattenuationratiocomparedtoliverbiopsy
AT naglaaallamahmed assessmentofhepaticsteatosisofpotentiallivingdonorbeforelivertransplantationusingliverspleenctattenuationratiocomparedtoliverbiopsy
AT mohamedmohamedhouseni assessmentofhepaticsteatosisofpotentiallivingdonorbeforelivertransplantationusingliverspleenctattenuationratiocomparedtoliverbiopsy
AT ahmedmohamedelrefaie assessmentofhepaticsteatosisofpotentiallivingdonorbeforelivertransplantationusingliverspleenctattenuationratiocomparedtoliverbiopsy
AT manalibrahimgomaa assessmentofhepaticsteatosisofpotentiallivingdonorbeforelivertransplantationusingliverspleenctattenuationratiocomparedtoliverbiopsy